POST Facilitation for Community Dwelling Older Adults (POST-RCT)

NCT04070183 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 389

Last updated 2025-11-26

No results posted yet for this study

Summary

We propose to study the effects of Physician Orders for Scope of Treatment (POST) Facilitation in a randomized controlled trial in a population of community dwelling older adults who qualify for POLST facilitation, including those with normal cognition and those with Alzheimer's Disease and Related Disorders.

Conditions

Interventions

BEHAVIORAL

POST Facilitation

Advanced steps is initiated as a component of quality end-of-life care for frail elders and those whose death in the next 12 months would not be unexpected. The AS planning conversation is focused on goals of care to make timely, proactive, and specific end-of-life decisions. Ideally, these decisions are converted into medical orders that can be followed throughout the continuum of care. The Physician Orders for Life-Sustaining Treatment (POLST) program is the nationally recognized model for this stage of planning.

BEHAVIORAL

Home Safety Evaluation

Nurse evaluation and education on how to improve safety at home for community dwelling older adults (examples of education and evaluation includes fall risks, fire and carbon monoxide (CO) detectors, transferring safety (e.g. in and out of the tub, bed, etc.) and others.

Sponsors & Collaborators

  • National Institute on Aging (NIA)

    collaborator NIH
  • National Institutes of Health (NIH)

    collaborator NIH
  • Regenstrief Institute, Inc.

    collaborator OTHER
  • Indiana University Health

    collaborator OTHER
  • Eskenazi Health

    collaborator OTHER
  • Respecting Choices

    collaborator UNKNOWN
  • Indiana University

    lead OTHER

Principal Investigators

  • Alexia M Torke, MD, MS · Regenstrief Institute, Indiana University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-11
Primary Completion
2025-07-29
Completion
2025-07-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04070183 on ClinicalTrials.gov